| 英文别名 |
(R)-N-(5-(3-Hydroxypyrrolidin-1-yl)-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-2-(2-methylpyridin-4-yl)oxazole-4-carboxamide;N-[5-[(3R)-3-Hydroxypyrrolidin-1-yl]-2-morpholin-4-yl-[1,3]oxazolo[4,5-b]pyridin-6-yl]-2-(2-methylpy;CA-4948;Emavusertib;MH5DMF9JKY;CA4948;4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)-;N-[5-[(3R)-3-hydroxypyrrolidin-1-yl]-2-morpholin-4-yl-[1,3]oxazolo[4,5-b]pyridin-6-yl]-2-(2-methylpyridin-4-yl)-1,3-oxazole-4-carboxamide;2-(2-methylpyridin-4-yl)-N-[2;AU4948;N-(5-((3R)-3-Hydroxy-1-pyrrolidinyl)-2-(4-morpholinyl)oxazolo(4,5-b)pyridin-6-yl)-2-(2-methyl-4-pyridinyl)-4-oxazolecarboxamide;Z3769318307;1801344-14-8;Emavusertib [INN];compound 24 [PMID: 33335659];N-{5-[(3R)-3-hydroxypyrrolidin-1-yl]-2-(morpholin-4-yl)[1,3]oxazolo[4,5-b]pyridin-6-yl}-2-(2-methylpyridin-4-yl)-1,3-oxazole-4-carboxamide;s9779;DTXSID001103300;GTPL10152;2-(2-methylpyridin-4-yl)-N-[2-morpholin-4-yl-5-[(3R)-3-oxidanylpyrrolidin-1-yl]-[1,3]oxazolo[4,5-b]pyridin-6-yl]-1,3-oxazole-4-carboxamide;Interleukin-1 Receptor-associated Kinase 4 Inhibitor CA-4948;Emavusertib (USAN/INN);AC-36757;UNII-MH5DMF9JKY;compound 24 (PMID: 33335659);Emavusertib (CA-4948);DA-61991;N-[5-[(3R)-3-Hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)-4-oxazolecarboxamide;SCHEMBL16896638;CHEMBL4783351;Emavusertib(CA-4948);CA 4948;Emavusertib [WHO-DD];G60989;AU-4948;N-(5-((3R)-3-Hydroxypyrrolidin-1-yl)-2-(morpholin-4- yl)(1,3)oxazolo(4,5-b)pyridin-6-yl)-2-(2-methylpyridin-4- YL)-1,3-oxazole-4-carboxamide;HY-135317;4-Oxazolecarboxamide, N-(5-((3R)-3-hydroxy-1-pyrrolidinyl)-2-(4-morpholinyl)oxazolo(4,5-b)pyridin-6-yl)-2-(2-methyl-4-pyridinyl)-;N-{5-[(3R)-3-hydroxypyrrolidin-1-yl]-2-(morpholin-4-yl)-[1,3]oxazolo[4,5-b]pyridin-6-yl}-2-(2-methylpyridin-4-yl)-1,3-oxazole-4-carboxamide;NSC-824184;D12411;N-(5-((3R)-3-HYDROXYPYRROLIDIN-1-YL)-2-(MORPHOLIN-4-YL)(1,3)OXAZOLO(4,5-B)PYRIDIN-6-YL)-2-(2-METHYLPYRIDIN-4-YL)-1,3-OXAZOLE-4-CARBOXAMIDE;WHO 11558;CS-0111301;AU 4948;BDBM50547964;Emavusertib [USAN:INN];Emavusertib [USAN];IRAK4 Inhibitor CA-4948;NSC824184;AKOS040759627;MS-29134;FJ0;EX-A4736 |